This retrospective study analyzes overall survival and relapse-free survival after mastectomy and survival after recurrence of 302 patients with metastatic breast cancer. In the whole group the median survival after mastectomy is 99 months: 5-year survival rate is 68.4\% and 10-year survival rate is 38.5\%. The median survival from relapse was 36 months: 5-year and 10-year survival rates were respectively 26.8 and 18.9\%. Various subsets of patients divided according to several prognostic factors have been analyzed.

Survival of patients with relapsing breast cancer: analysis of 302 patients / R., Lionetto; P., Pronzato; G. F., Bertelli; A., Ardizzoni; Conte, Pierfranco; R., Rosso. - In: ONCOLOGY. - ISSN 0030-2414. - STAMPA. - 43:(1986), pp. 278-282.

Survival of patients with relapsing breast cancer: analysis of 302 patients.

CONTE, Pierfranco;
1986

Abstract

This retrospective study analyzes overall survival and relapse-free survival after mastectomy and survival after recurrence of 302 patients with metastatic breast cancer. In the whole group the median survival after mastectomy is 99 months: 5-year survival rate is 68.4\% and 10-year survival rate is 38.5\%. The median survival from relapse was 36 months: 5-year and 10-year survival rates were respectively 26.8 and 18.9\%. Various subsets of patients divided according to several prognostic factors have been analyzed.
1986
43
278
282
Survival of patients with relapsing breast cancer: analysis of 302 patients / R., Lionetto; P., Pronzato; G. F., Bertelli; A., Ardizzoni; Conte, Pierfranco; R., Rosso. - In: ONCOLOGY. - ISSN 0030-2414. - STAMPA. - 43:(1986), pp. 278-282.
R., Lionetto; P., Pronzato; G. F., Bertelli; A., Ardizzoni; Conte, Pierfranco; R., Rosso
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/738292
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 17
social impact